Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leadsKamila Kaminska(Lund University), Eng‐Hui Chew(National University of Singapore)OncotargetMay 24, 201610.18632/oncotarget.9579Cited by 27SaveCiteExport RISWatch citationsRelated PapersInduction of Tumor Cell Death through Targeting Tubulin and Evoking Dysregulation of Cell Cycle Regulatory Proteins by Multifunctional Cinnamaldehydes|PLoS ONE|2012|41Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer|Breast Cancer Research|2021|40